Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the name of the new company to be formed by the planned combination of Mylan and Upjohn, a division of Pfizer, will be Viatris (pronounced ‘viǝ-trīs).
Industry News
Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination
